These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15808191)

  • 21. Transient retinal effects of 5,6-dimethylxanthenone-4-acetic acid (DMXAA, ASA404), an antitumor vascular-disrupting agent in phase I clinical trials.
    Jameson MB; Sharp DM; Sissingh JI; Hogg CR; Thompson PI; McKeage MJ; Jeffery M; Waller S; Acton G; Green C; Baguley BC
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2553-9. PubMed ID: 19387077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apparent disappearance of choroidal neovascularization after initial photodynamic therapy with verteporfin.
    Sawa M; Ohji M; Gomi F; Kusaka S; Tano Y; Bressler NM
    Arch Ophthalmol; 2002 Nov; 120(11):1588-90. PubMed ID: 12427082
    [No Abstract]   [Full Text] [Related]  

  • 23. Exudative complications after photodynamic therapy.
    Holz ER; Linares L; Mieler WF; Weinberg DV
    Arch Ophthalmol; 2003 Nov; 121(11):1649-52. PubMed ID: 14609931
    [No Abstract]   [Full Text] [Related]  

  • 24. Photodynamic therapy in patients with idiopathic choroidal neovascularization.
    Karacorlu M; Karacorlu S; Ozdemir H
    Jpn J Ophthalmol; 2004; 48(4):422-4. PubMed ID: 15295678
    [No Abstract]   [Full Text] [Related]  

  • 25. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
    Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
    Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choroidal neovascularization from a presumed subretinal nematode.
    Chen FK; Kennedy C
    Arch Ophthalmol; 2007 Sep; 125(9):1298-9. PubMed ID: 17846381
    [No Abstract]   [Full Text] [Related]  

  • 27. Abnormal multifocal electroretinogram (mfERG) in ethambutol toxicity.
    Kardon RH; Morrisey MC; Lee AG
    Semin Ophthalmol; 2006; 21(4):215-22. PubMed ID: 17182409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences.
    Bressler NM; Bressler SB
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):624-8. PubMed ID: 10711673
    [No Abstract]   [Full Text] [Related]  

  • 29. Photodynamic therapy for angioid streaks.
    Browning AC; Amoaku WM; Chung AK; Ghanchi F; Harding SP; Musadiq M; Yang YC; Talks SJ
    Ophthalmology; 2007 Aug; 114(8):1592. PubMed ID: 17678709
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic and therapeutic challenges.
    McDonald HR
    Retina; 2002 Aug; 22(4):487-92. PubMed ID: 12172117
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of lesion size on treatment benefit with photodynamic therapy.
    Essex RW
    Clin Exp Ophthalmol; 2004 Aug; 32(4):452-3. PubMed ID: 15281993
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
    Hariprasad SM; Shah GK
    Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescein angiographic changes in acute toxic retinopathy associated with polypharmacy.
    Shaikh S; Shaikh N; Blumenkranz MS
    Retina; 2000; 20(6):685-8. PubMed ID: 11131433
    [No Abstract]   [Full Text] [Related]  

  • 34. Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula.
    Lee SC; Seong YS; Kim SS; Koh HJ; Kwon OW
    Ophthalmologica; 2004; 218(3):193-201. PubMed ID: 15103216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy.
    Ergun E; Tittl M; Stur M
    Arch Ophthalmol; 2004 Jan; 122(1):37-41. PubMed ID: 14718292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy with verteporfin for choroidal neovascularization complicating angioid streaks.
    Karadimas P; Bouzas EA
    Ophthalmic Surg Lasers Imaging; 2004; 35(1):78-80. PubMed ID: 14750772
    [No Abstract]   [Full Text] [Related]  

  • 37. [Photodynamic therapy carefully destroys neovascularization of the retina].
    Ophthalmologe; 2003 Feb; 100(2):1 p following 174. PubMed ID: 12650171
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of early retreatment with the standard regimen in verteporfin therapy of neovascular age-related macular degeneration.
    Michels S; Wachtlin J; Gamulescu MA; Heimann H; Prünte C; Inhoffen W; Krebs I; Schmidt-Erfurth U
    Ophthalmology; 2005 Dec; 112(12):2070-5. PubMed ID: 16225928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinal hemorrhage after photodynamic therapy in patients with subfoveal choroidal neovascularization caused by age-related macular degeneration.
    Theodossiadis GP; Panagiotidis D; Georgalas IG; Moschos M; Theodossiadis PG
    Graefes Arch Clin Exp Ophthalmol; 2003 Jan; 241(1):13-8. PubMed ID: 12545287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photodynamic therapy for choroidal neovascular membrane secondary to optic nerve drusen.
    Chaudhry NA; Lavaque AJ; Shah A; Liggett PE
    Ophthalmic Surg Lasers Imaging; 2005; 36(1):70-2. PubMed ID: 15688974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.